Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review

Сочетание непрерывного мониторинга глюкозы и инсулиновых помп для автоматической настройки базальной инфузии инсулина при лечении сахарного диабета: обзор
Andrea Facchinetti, Martina Vettoretti
2019-03-29

Type 1 diabetesautomated basal insulincontinuous glucose monitoringhypoglycemia preventioninsulin pumps
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not produce any insulin, maintaining the blood glucose (BG) concentration as much as possible within the safety range (70-180 mg/dl) allows avoiding short- and long-term complications. The tuning of exogenous insulin infusion can be difficult, especially because of the inter- and intra-day variability of physiological and behavioral factors. Continuous glucose monitoring (CGM) sensors, which monitor glucose concentration in the subcutaneous tissue almost continuously, allowed improving the detection of critical hypo- and hyper-glycemic episodes. Moreover, their integration with insulin pumps for continuous subcutaneous insulin infusion allowed developing algorithms that automatically tune insulin dosing based on CGM measurements in order to mitigate the incidence of critical episodes. In this work, we aim at reviewing the literature on methods for CGM-based automatic attenuation or suspension of basal insulin with a focus on algorithms, their implementation in commercial devices and clinical evidence of their effectiveness and safety.
1
Continuous glucose monitoring improves detection of critical hypoglycemic and hyperglycemic episodes compared with intermittent glucose assessment.
2
Integrating CGM sensors with insulin pumps enables algorithms to automatically attenuate or suspend basal insulin delivery based on glucose measurements.
3
Maintaining blood glucose within the 70–180 mg/dl safety range is essential for reducing short- and long-term complications in Type 1 diabetes.
4
The review evaluates algorithmic approaches, implementation in commercial devices, and clinical evidence regarding their effectiveness and safety.
5
The reviewed methods address physiological and behavioral variability by dynamically adjusting basal insulin infusion to reduce critical glucose excursions.

CGM-integrated insulin pump therapy for individuals with Type 1 diabetes

CGM-based automatic attenuation or suspension of basal insulin infusion and its clinical effectiveness and safety

Publication Details
Publication Date
2019-03-29
Journal
Publisher
ISSN
Cited by
52
Access Type
Author Information
Authors
Andrea Facchinetti
Martina Vettoretti
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%